ArticleReproductive biology and endocrinology : RB&E2026
Enhanced genetic diagnosis in early pregnancy loss: an integrated approach using CNV-Seq and STR genotyping.
Article in Reproductive biology and endocrinology : RB&E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeChromosomal abnormalities are a leading cause of early pregnancy loss (EPL). While copy number variation sequencing (CNV-seq) is gradually applied in clinical practice, its sensitivity for detecting triploidy and uniparental disomy (UPD) remains limited. This study aimed to evaluate whether integrating CNV-seq with short tandem repeat (STR) genotyping could improve diagnostic performance in EPL.
methodsIn this study, 572 EPL samples were examined using CNV-seq combined with STR genotyping to detect chromosomal abnormalities, including triploidy and UPD, and to explore STR-based approaches for identifying the origin of abnormal chromosomes. Selected results were validated using karyotyping, CMA, MLPA, or FISH when necessary.
resultsChromosomal abnormalities were identified in 313 cases (54.7%), including autosomal aneuploidies (52.4%), CNVs (13.4%), sex chromosome aneuploidies (11.5%), multiple trisomies (3.5%), and mosaicism (3.5%). STR genotyping identified 38 additional cases (35 triploidy, 3 UPD) missed by CNV-seq, elevating the overall diagnostic yield by 6.6% (p < 0.05). Parental origin analysis revealed distinct distribution patterns: 69,XXY triploidies were predominantly of paternal origin (80.8%), whereas 69,XXX cases were mostly maternal (88.9%); all detected UPD cases were paternally derived. Among 134 common autosomal aneuploidies, maternal meiotic errors accounted for 91.8% of occurrences.
conclusionThe combination of CNV-seq and STR genotyping significantly improves the detection efficiency of triploidy, mosaicism, and other complex chromosomal anomalies, compensating for crucial limitations of conventional CNV-seq. Further STR-based parental tracing facilitates the identification of chromosomal aberration origins and reveals error formation patterns, thereby providing robust evidence for clinical etiological interpretation of early pregnancy loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.